ASKA Pharmaceutical Holdings Co.,Ltd.
JPX: 4886.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Takashi Yamaguchi
- Employees
- 762
- Headquarters
- Tokyo, Japan
- IPO year
- 2021
- Market cap
- ¥83.3B
- Website
- https://www.aska-pharma-hd.co.jp
Loading 4886…
Loading profile data…Frequently asked questions about 4886
What does ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) do?
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and ex...
Where does 4886.T trade?
ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) trades on the Tokyo Stock Exchange.
What sector is 4886.T in?
ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ASKA Pharmaceutical Holdings Co.,Ltd.?
Takashi Yamaguchi is the chief executive officer of ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T).
Where is ASKA Pharmaceutical Holdings Co.,Ltd. headquartered?
ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Japan.
Does 4886.T pay a dividend?
Yes — ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) paid a trailing twelve-month dividend of JPY 55.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4886.T go public?
ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) completed its initial public offering in 2021.